Live Breaking News & Updates on Gene Merutka|Page 1
Stay updated with breaking news from Gene merutka. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sapience Therapeutics Awarded SBIR Phase I Grant from National Institute of Allergy and Infectious Diseases News provided by Share this article Share this article HARRISON, N.Y., May 18, 2021 /PRNewswire/ Sapience Therapeutics, Inc., a biotechnology company focused on the discovery and development of peptide therapeutics to address difficult to treat oncology indications, announced today that it was awarded a Small Business Innovative Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to investigate the inhibition of SARS-CoV-2 infection with a pan-coronavirus anti-viral peptide. The grant will provide funds over two years to support the discovery and development of peptide therapeutics against coronaviruses, including SARS-CoV-2 (COVID-19). ....
Sapience Therapeutics Awarded SBIR Phase I Grant from National Institute of Allergy and Infectious Diseases prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.